Immunological and aetiological aspects of macular degeneration.
about
Statins for age-related macular degenerationStatins for age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationStatins for age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationA common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degenerationStatins for age-related macular degenerationNatural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal DegenerationThe proteomics of drusenContribution of microglia-mediated neuroinflammation to retinal degenerative diseasesAutoimmune retinopathy.Recent developments in the management of dry age-related macular degenerationTransforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptidesCirculating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and ApoptosisMicroglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD.Photoreceptor synapses degenerate early in experimental choroidal neovascularization.Emerging biological therapies for age-related macula degeneration.The complement system and age-related macular degeneration.Macrophages inhibit neovascularization in a murine model of age-related macular degenerationMacular degeneration: recent advances and therapeutic opportunities.Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.Complement factor H: using atomic resolution structure to illuminate disease mechanisms.Genetic loci that control the size of laser-induced choroidal neovascularizationAssociation of superoxide anions with retinal pigment epithelial cell apoptosis induced by mononuclear phagocytesPresent and possible therapies for age-related macular degeneration.Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.Animal models of choroidal and retinal neovascularization.Microglia-derived IL-1β promotes chemokine expression by Müller cells and RPE in focal retinal degeneration.Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils.Risk factors for age-related maculopathyThe role of CRP and inflammation in the pathogenesis of age-related macular degeneration.Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium.Glyt-1 expression in cultured human Müller cells and intact retinae.The Immune System and AMDMonozygotic twins with polypoidal choroidal vasuculopathy.Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularizationMacrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.New insights and new approaches toward the study of age-related macular degeneration.
P2860
Q24188161-E2C68058-A46E-4BB7-A0EA-E6C6523B4895Q24201178-F4027D39-B8A7-4870-9C43-B69B75DD2E5AQ24201624-4F249A2F-AED8-4D76-9619-47CE83603988Q24240102-BD35A1F8-67FE-4C09-BB7A-9D1ABBAB1500Q24243503-DB8B484B-EAC5-456B-A58C-74DD6D60CF34Q24523983-36937F10-05C9-4E5B-B0EF-6BFD30D32BE0Q26470515-84101CC2-0CB2-4D97-85AA-27B2D5711E8EQ26799250-F1F0B143-5981-4993-BC13-BD3C3C6849FBQ26997523-ACEE4BC1-F331-46A2-9A1E-0FF1A5C3A1CAQ27007111-41FA3BC9-CD67-4FD8-9250-DD944DC62300Q27694736-9E60173B-3148-4B8E-8800-C92778AC6E80Q28088816-14D0FD70-FF9C-4282-A015-0BC0A628C1FCQ28533494-BDC72E8C-4738-4B1C-8DAC-A4FF95241FFFQ28551885-7D0054D9-F7EA-4132-B24D-84BE544E498CQ30912692-F7B45EB7-C52E-4CBC-9339-CB4859A70C82Q33211350-6573BF63-3D8C-4139-9BA1-71EAF7EC95C1Q33224360-B550AFED-DEC6-48DA-9FE5-DC81FCF53300Q33231562-1F0465AD-2070-4519-A921-34D36F6BC23FQ33253660-116F5A09-A24C-4404-910C-ED0FDA8F7096Q33260025-446DE0AA-A063-416B-96A4-9AFBE7C656CCQ33263472-7B46F207-1FAB-4A3C-85E5-87EF1455BB2DQ33382097-09E6680E-4FD2-40C7-8998-179E60F9582CQ33411677-173594C5-D08A-4877-95CA-3F533C5FB8ACQ33449191-E7FE2D61-2993-4808-A15C-16A56AF1D275Q33562731-26D951BA-7F08-4DBB-B7C8-3E549B0F11C3Q33577384-E7E5073E-D782-4210-9C62-7194DDEDF9DAQ33582933-E1B187A8-5A70-404A-AB0D-2C23DF4D9422Q33602051-1C22763C-3D4A-4A2F-ABF1-3C6CC449CABFQ33657934-D5C6D592-EB37-4AFD-8381-A9C9F6A0ABE1Q33720834-18F3B05A-D627-4E1B-BEA2-ADEBBCB6CCE6Q33773157-931412A1-3E1F-4FAC-ABF0-5A804827EAF8Q33840832-7751BF1E-EBC1-4D71-81DE-ED8C21A00EFDQ33857403-83E011A7-3661-4BC2-AB58-AFBA45EBBCCCQ33947481-F2778599-847D-4F50-B247-D97D17C98100Q34003743-1252C984-D250-41F1-B765-640B75CC9D4AQ34043320-A655D48E-8FE9-4656-BC4A-B4E0532136ECQ34114772-B58CF28F-2FD3-4F03-A624-E44D70D07629Q34206305-9DE98327-621C-4022-8E18-A33134CEE9D7Q34263026-1B541077-10F2-49A8-95CC-C08EF17D8977Q34378526-34EA879F-F54E-476C-9248-662F95D5317B
P2860
Immunological and aetiological aspects of macular degeneration.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunological and aetiological aspects of macular degeneration.
@ast
Immunological and aetiological aspects of macular degeneration.
@en
Immunological and aetiological aspects of macular degeneration.
@nl
type
label
Immunological and aetiological aspects of macular degeneration.
@ast
Immunological and aetiological aspects of macular degeneration.
@en
Immunological and aetiological aspects of macular degeneration.
@nl
prefLabel
Immunological and aetiological aspects of macular degeneration.
@ast
Immunological and aetiological aspects of macular degeneration.
@en
Immunological and aetiological aspects of macular degeneration.
@nl
P2093
P1476
Immunological and aetiological aspects of macular degeneration.
@en
P2093
Gillies MC
Madigan MC
Penfold PL
P304
P356
10.1016/S1350-9462(00)00025-2
P577
2001-05-01T00:00:00Z